USA VC Funds

Oriza Ventures is a venture capital fund that focuses on early-stage technology investments, primarily in North America. Founded by seasoned entrepreneurs and investors, Oriza Ventures supports startups with disruptive technological pursuits and innovative business ideas. The firm's portfolio spans various industries, including artificial intelligence, big data, Internet of Things, consumer internet, and medical and health products. The team at Oriza Ventures includes founding partners John Yu, Alex Liang, and Yao Xiao, who bring extensive experience in venture capital and entrepreneurship. They leverage their backgrounds to provide strategic guidance and resources to their portfolio companies. Oriza Ventures' portfolio features a diverse range of companies such as Ayla Networks, an IoT platform for smart home appliances; Bolt, an online checkout platform; and InterVenn Biosciences, which uses AI-driven mass spectrometry for medical applications.

Orlando Health Ventures is the corporate venture capital arm of Orlando Health, one of Central Florida's largest nonprofit integrated healthcare systems, established in 2018 and based in Orlando, Florida. The unit sits inside the Orlando Health Strategic Innovations group alongside The Foundry, Orlando Health's internal innovation and rapid-prototyping engine, giving portfolio companies direct access to clinicians, operating executives, and service-line leaders for evaluation, piloting, and commercial validation. The fund targets early-stage companies whose technologies have the potential to transform care delivery, clinical workflows, and patient outcomes. Orlando Health Ventures has made approximately nine disclosed investments concentrated in medical devices and digital health. Portfolio companies include 410 Medical (rapid IV medication delivery, with a Series B-II round in March 2025 as the firm's most recent disclosed investment), Biostable Science and Engineering (Austin-based heart-valve repair device as an alternative to replacement, with roughly $1.25 million deployed), and Vesalio (neurovascular thrombectomy devices whose NeVa VS system launched at Wellstar Health System in Atlanta). The fund participates in seed through Series B rounds alongside peer health-system corporate venture arms such as UPMC Enterprises. What distinguishes Orlando Health Ventures is its combination of clinician-led diligence and operational pilot capability. Portfolio companies can run structured pilots within the Orlando Health system, gaining real-world evidence and commercial traction while the fund's investment committee evaluates growth trajectory and return potential. The result is a capital partner that brings both funding and a credible path to enterprise healthcare customers.

OS Fund, established in 2014 by Bryan Johnson, is a venture capital firm that invests in early-stage science and technology companies. The firm focuses on sectors such as genomics, synthetic biology, computationally derived therapeutics, advanced materials, and diagnostics. The goal is to support companies that are developing groundbreaking technologies and solutions to solve significant real-world challenges​. Bryan Johnson, who co-founded the fund, initially invested $100 million of his own money after selling his previous company, Braintree, to PayPal for $800 million. The fund seeks out entrepreneurs who are future-oriented and possess the ambition to create a better future for humanity​. OS Fund has a strong portfolio, including companies like Ginkgo Bioworks, Atomwise, and Verge Genomics. These companies are at the forefront of innovation, working on projects such as self-fertilizing crops, storing data in DNA, and designing new proteins.

Osage Venture Partners (OVP) is a Philadelphia-based venture capital firm that specializes in early-stage investments in B2B software companies. The firm primarily focuses on companies driving innovation in the future of work and education sectors. Since its inception, OVP has invested in over 30 companies, with a strong preference for those with recurring revenue models and deep domain expertise. Notable investments in their portfolio include companies like Sidecar, RiskLens, and ExecOnline. OVP typically invests in post-revenue companies with a revenue run rate between $500,000 and $3 million, focusing mainly on Seed and Series A rounds. They have a hands-on approach, often leading or co-leading investments and joining the boards of their portfolio companies. OVP emphasizes the importance of partnerships, leveraging their extensive network of technology executives and industry experts to support the growth and success of the companies they invest in. Their team is comprised of seasoned investors and former operators who provide strategic guidance and operational support to entrepreneurs.

OSF Ventures is the corporate venture capital arm of OSF HealthCare, a 15-hospital nonprofit integrated health system operating across Illinois and Michigan. Founded in 2015 and headquartered in Peoria, Illinois, OSF Ventures sits within OSF Innovation and invests financially, operationally, and strategically in healthcare companies whose technologies can improve patient outcomes, enhance patient experience, and reduce the cost of care. Mayank Taneja, Vice President of Venture Investments, leads a seven-person team across three successive fund vintages that have grown cumulative AUM to $250 million, anchored by Fund III, a $100 million vehicle launched in January 2022 with a thesis tilt toward alternative care modalities and healthcare workforce retention. The firm participates as a syndicate member at Series A through growth stages and has made approximately 37 investments spanning health information technology, medical devices, therapeutics, diagnostics, and technology-enabled care delivery. The portfolio has produced notable exits including Current Health (acquired by Best Buy in 2021), Health Catalyst (NASDAQ IPO in 2019), and SilverCloud Health (acquired by Amwell in 2021). Recent deployments include Hellocare.ai, Cala, ShiraTronics, Cardiosense ($15.1 million Series A for an AI heart disease biomarker platform), 410 Medical ($6.3 million Series B for pediatric sepsis), and Digital Diagnostics ($75 million Series B, autonomous AI diagnostics). OSF Ventures brings more than just capital to portfolio companies. Its status as an active operating health system means founders gain access to clinical validation environments, practitioner networks, and patient populations that can meaningfully accelerate regulatory and commercial timelines, making the fund a strategic partner in addition to a financial backer.

OSS Capital, founded in 2018 by Joseph Jacks, Heather Meeker, and Nick White, is a San Francisco-based venture capital firm dedicated to the commercial open-source software (COSS) sector. OSS Capital has a strong focus on early-stage investments in enterprise applications, infrastructure, and innovative technology companies. Notable investments include companies like Plane, AppFlowy, and W4 Games. Their recent investments reflect their commitment to supporting transformative technologies in project management, software development, and media entertainment. OSS Capital's strategy emphasizes backing companies with robust open-source communities and leveraging their extensive network of co-investors, which includes notable figures like Naval Ravikant and funds like Sequoia Capital. OSS Capital's geographic focus spans the United States, India, and other international markets. The team, led by General Partner Joseph Jacks and supported by partners Heather Meeker and Bruce Perens, brings significant expertise in both the open-source and commercial software landscapes. They prioritize investments in companies that can benefit from deep technical insights and strategic support, ensuring these startups can scale effectively and sustainably​.

OTV (formerly Olive Tree Ventures) is a global specialist venture capital firm exclusively dedicated to digital health, founded in 2015 and headquartered in Tel Aviv, Israel with additional offices in New York, Montreal, and Shanghai. Co-founded by General Partners Mayer Gniwisch, Amir Lahat, and Alejandro Weinstein, who together bring backgrounds spanning healthcare, technology, private equity, and financial services, the firm is widely recognized as Israel's only major VC whose primary investment focus is digital health. Partner Manor Zemer complements the founding team. OTV closed a dedicated $170 million digital-health growth fund in December 2020, anchoring its international expansion including the opening of its Asia office in Shanghai. The firm leads rounds across 45 investments and covers the full arc of digital health: telemedicine and virtual care, genomics, AI-powered clinical decision and diagnostics platforms, digital biomarkers, precision medicine, and next-generation medical-device software. Notable portfolio companies include TytoCare (remote examination kit, whose $50 million round OTV led alongside Insight Partners and Qualcomm Ventures) and Scopio Labs ($16 million Series B that OTV led in December 2023, advancing digital microscopy and AI pathology). Realized exits include Lemonaid Health (acquired by 23andMe) and Emedgene (acquired by Illumina). OTV focuses particularly on companies reaching commercial maturity, partnering with founders to navigate regulatory, reimbursement, and enterprise sales challenges across five continents. Its combination of Israeli innovation sourcing, US capital-market relationships, and Asian commercial networks makes it a genuinely global platform for digital health at growth stage.

OurCrowd, founded in 2013 and headquartered in Jerusalem, is a leading global venture capital platform. It offers accredited investors access to pre-vetted startups, exclusive venture funds, and alternative investments. The firm’s portfolio covers sectors such as healthcare, AI, robotics, energy, and fintech, with notable investments in Beyond Meat, JumpCloud, and Lemonade. Beyond Meat, a leader in plant-based foods, and Lemonade, an AI-driven insurance company, both had successful IPOs and continue to thrive. OurCrowd’s investment strategy involves thorough due diligence and active support for portfolio companies, ranging from seed to growth stages. They typically invest between $1 million and $5 million, offering strategic guidance and access to a global network of co-investors and operational support​. The firm operates globally, with a strong presence in Israel and the U.S., and investments in Europe, Asia, and Latin America. This global reach allows them to tap into diverse markets and innovative ecosystems. Led by CEO Jon Medved, OurCrowd’s team includes investment professionals across multiple offices worldwide, ensuring a comprehensive approach to emerging technologies and market opportunities. Startups seeking investment should highlight their innovation, scalability, and market potential, approaching OurCrowd through their network or platform to increase funding chances

Outbound Ventures, founded in 2015 and based in New York, focuses on early-stage investments in tech-enabled consumer-facing companies. They have made 54 investments and have had 16 successful exits, including companies like Mented Cosmetics, Hydra Studios, and Fleur Marché. The firm is led by co-founders Jimmy Thermiotis, Luis Gonzalez, and Nael Rasamny. Outbound Ventures prioritizes companies with self-aware and adaptable founding teams and leverages their extensive network across Latin America, the U.S., and the U.K. to support the growth of their portfolio companies. Notable investments include Treinta, a fintech company in Colombia; Nabis, a logistics software for the cannabis industry; and Moonshot Brands, a company focused on e-commerce and consumer goods. Their investment strategy typically involves rounds ranging from seed to Series A, with an average round size of $8 million.

Outset Capital is a specialized early-stage venture capital firm based in San Francisco, driven by a team of AI practitioners and serial entrepreneurs. Their investment focus is on AI, dev tools, robotics, and the future of work, making them a go-to partner for cutting-edge tech startups. They are particularly known for backing companies at the earliest stages, often before anyone else, with small but strategic investments that do not lead rounds. Instead, Outset prefers to add significant value through their hands-on approach, leveraging their deep operational experience to help founders scale from 0 to 1. Notable portfolio companies include Datology AI, Reflex, and SimpleHash, showcasing their focus on AI and software innovation. Outset Capital typically co-invests with leading firms like Andreessen Horowitz, Sequoia, and Lux Capital, reflecting their strong network and collaborative approach. Led by Ali Rohde, Josh Albrecht, and Kanjun Qiu, all of whom are based in San Francisco, the team’s unique blend of technical expertise and entrepreneurial success offers startups robust support beyond just capital. They maintain an active presence in the Bay Area’s startup community, organizing events and fostering a strong network of founders, engineers, and researchers. For startups looking to partner with Outset, the team values integrity, founder alignment, and a shared vision for long-term impact, making them more than just investors—they’re builders backing builders.

Outsiders Fund, founded in 2020 and based in New York, focuses on early-stage investments in disruptive technologies. The fund backs founders challenging traditional industries with innovative solutions. Outsiders Fund has a diverse portfolio across various sectors, including enterprise software, healthcare, cybersecurity, and aerospace. Notable investments include RaySecur, which provides mail and package security solutions using mmWave imaging technology; Casana, which offers remote patient monitoring via a smart toilet seat; and Dyania Health, which matches patients for clinical trials. Another significant investment is in Apex, a company focused on spacecraft manufacturing​. The fund typically invests in seed and early-stage rounds, with an average round size of $11M. Recent investments include Gradial, a generative AI content creation platform, and PaintJet, a robotics company specializing in painting commercial spaces. Led by Managing Partner Theodore Seem and supported by a team of experienced professionals, Outsiders Fund aims to partner with founders to drive growth and innovation in their respective fields. Their approach involves close collaboration with portfolio companies, providing strategic guidance and facilitating key industry connections.

Overlooked Ventures is a venture capital firm founded in 2021, based in Columbus, Ohio, and focused on investing in early-stage companies led by historically underrepresented founders, particularly women, people of color, and other overlooked communities. Their goal is to break down barriers and promote diversity within the tech and startup ecosystems by providing capital, mentorship, and support to promising entrepreneurs. The firm, led by founding partners Brandon Brooks and Janine Sickmeyer, prioritizes sectors like health tech, fintech, climate tech, and social impact startups. With check sizes ranging from $150,000 to $1 million, Overlooked Ventures invests primarily in pre-seed, seed, and Series A stages. Their portfolio includes companies such as CarpeDM, Lalo, and Blooming Health, reflecting their focus on innovation and inclusivity. Overlooked Ventures aims to address the gaps in funding for diverse founders, helping them access resources and support that historically have been unavailable to them​.

AngelList, a prominent platform for startup investments, has facilitated investments in over 2,698 startups through its innovative syndicate and fund structures. Some of its notable investments include companies like Brex, Postmates, Cruise, and PillPack, which have grown significantly in their respective industries. AngelList offers various investment opportunities, including traditional funds, syndicates, and rolling funds, allowing investors to back startups on a deal-by-deal basis. The platform has democratized early-stage investing by providing individual accredited investors access to high-quality investment opportunities, often in collaboration with top-tier venture capital firms. For instance, AngelList has supported the growth of companies like Notion, Iterable, and MoonPay, providing them with the necessary capital to scale. Their full-service fund management capabilities streamline the investment process, from fund formation to managing cap tables and tax preparation, making it easier for new and experienced investors alike to participate in venture capital.

Overton Venture Capital, based in New York, is a woman-led early-stage VC firm with a sharp focus on investing in seed and early-stage companies that are driving transformative changes in technology and consumer behavior. The fund is particularly interested in sectors like digital health, fintech, edtech, and consumer products. Some of their notable investments include K Health, Stash, and Bringg, which highlight their commitment to backing companies with strong technological underpinnings poised for significant market disruption. The fund’s investment strategy revolves around identifying and supporting diverse founding teams that not only demonstrate innovative product vision but also exhibit fiscal discipline and rapid growth potential. Overton VC is known for its hands-on approach, leveraging the deep operational expertise of its partners to actively support portfolio companies in scaling their businesses. The team is led by co-founders Kerry Miller and Michael Nogen, both seasoned professionals with extensive experience in management consulting, corporate strategy, and entrepreneurship. They emphasize a collaborative, transparent partnership with founders, aiming to build businesses with sustainable, long-term value. Startups seeking investment are encouraged to have a clear path to revenue and a strong, integrity-driven leadership team.

Overture is an early-stage venture capital firm dedicated to addressing the climate crisis by investing in groundbreaking climate tech startups. With a $60 million debut fund, Overture focuses on sectors like energy, transportation, carbon management, and climate adaptation. The firm targets Pre-Seed, Seed, and Series A companies, typically writing checks of around $1.5 million. They invest across North America and Europe, supporting founders who are developing technologies that promote decarbonization and sustainable practices. What sets Overture apart is its strategic alignment with government policies. Each portfolio company receives in-kind support from Boundary Stone Partners, a leading government affairs firm. This partnership helps startups navigate regulatory complexities and unlock government grants, loans, and other funding opportunities. Their portfolio includes innovative companies like Antora Energy, Crux, and Forum Mobility. Founded by a team of former U.S. Department of Energy and White House appointees, Overture leverages its deep expertise in both public policy and venture capital to accelerate climate solutions. The fund’s mission is to empower startups to scale by not only providing capital but also unlocking federal, state, and municipal resources to help them succeed.

Overwater Ventures is an early-stage venture capital firm based in San Francisco, founded and led by Kristina Simmons, a former partner at Andreessen Horowitz and Chief of Staff at Khosla Ventures. The firm focuses on investing in breakthrough technologies that positively impact human health and the planet. Overwater Ventures closed its $20 million debut fund in April 2023, with backing from institutional family offices, experienced founders, and prominent investors like Vinod Khosla. The fund primarily targets sectors such as digital health, biotech, AI, robotics, climate tech, and future food. Notable portfolio companies include Overstory, which reduces power outages and wildfires, and Conceive, a fertility technology firm. Overwater Ventures is committed to providing holistic support to its founders, addressing not just business needs like marketing and fundraising but also personal well-being, including mental health and stress management.

OVO Fund, established in 2013 and headquartered in Palo Alto, California, specializes in early-stage venture capital investments, particularly in the pre-seed and seed stages. The firm focuses on backing "scary early-stage startups" with innovative ideas across various capital-efficient sectors. Their typical check size ranges from $250,000 to $500,000, with significant reserves for follow-on investments before the Series A stage. OVO Fund has a diverse portfolio of over 90 technology startups, including notable companies like Palantir, Wish, RelateIQ, Signifyd, Piazza, Addepar, and Juniper Square. Recent investments include companies such as Suma Wealth, a fintech company, and Clayful, an e-learning and wellness platform for children. The firm is led by experienced investors such as Eric Chen and Ilse Calderon, who provide strategic support to help their portfolio companies grow and succeed. OVO Fund is currently investing out of its second fund, which is valued at $35 million.

OVP Venture Partners (originally Olympic Venture Partners) was one of the Pacific Northwest's pioneer early-stage venture capital firms, founded in 1983 and headquartered in Kirkland, Washington, with an additional office in Portland, Oregon. Across nearly three decades of operation, OVP raised seven funds and managed more than $750 million in aggregate capital, led by Managing Directors Gerry Langeler, Chad Waite, and Bill Funcannon. The firm focused on information technology, software, digital media, communications, security, semiconductors, clean tech, and digital biology, with an emphasis on capital-efficient technology businesses in the western United States. OVP invested in approximately 102 companies across its history, generating 6 IPOs and 51 acquisitions. Early stakes in Qualcomm and Lam Research established the firm's track record. Later notable exits include NanoString Technologies (acquired by Bruker for $393 million in April 2024, OVP's most recent portfolio liquidity event), Cradlepoint, Fate Therapeutics, Aggregate Knowledge, Complete Genomics, Integrated Diagnostics, and RedSeal. The firm's seventh and final fund, OVP VII, was a $250 million 2006-vintage vehicle. In November 2012 OVP announced it would wind down and not raise an eighth fund, citing challenging fundraising conditions. OVP VII has since been liquidated. OVP Venture Partners is permanently closed to new investments. Its legacy portfolio has been fully managed to conclusion by the remaining partners, and the firm's track record stands as one of the most extensive in Pacific Northwest venture history, spanning four decades of technology investing and more than 50 successful exits across software, biotech, hardware, and communications.

Owl Ventures, founded in 2014 and based in Silicon Valley, is the largest venture capital firm dedicated to the education technology market, managing over $2 billion in assets. They specialize in investing across all stages from seed to late growth, focusing on transformative education companies. Notable investments include industry leaders like BYJU’s, MasterClass, Quizlet, and Newsela, which showcase their strategic emphasis on PreK-12, higher education, professional learning, and the intersection of EdTech with other sectors like FinTech and healthcare. Their investment strategy is hands-on, leveraging a global network of Limited Partners, distribution channels, and strategic partners to help portfolio companies scale effectively. Owl Ventures' approach includes support in talent acquisition, building syndicates, and navigating the education market's complexities. The firm is known for leading funding rounds and providing substantial check sizes, reflecting their active involvement in driving company growth and outcomes measurement. The team comprises experienced professionals like Managing Directors Ian Chiu, Tom Costin, Amit Patel, and Partner Malvika Bhagwat, each bringing deep domain expertise and a strong focus on education outcomes. Owl Ventures operates globally, with a strong presence in markets across North America, Europe, Asia, and Latin America, aiming to support innovative solutions that address the global skills gap and enhance educational accessibility and quality. Entrepreneurs seeking investment should note Owl Ventures’ preference for visionary leaders in EdTech, with an emphasis on scalable, impactful solutions. Approaching them with a clear demonstration of educational impact and market potential can significantly enhance partnership prospects.

Oxford Capital Partners, founded in 1999 and based in Oxford, UK, is a venture capital firm that focuses on investing in early-stage technology companies. The firm has invested approximately £500 million in over 100 businesses, emphasizing sectors such as fintech, digital health, artificial intelligence, and the future of retail. Their investment strategy leverages the UK's Enterprise Investment Scheme (EIS), providing tax advantages to investors and fostering innovation across the tech landscape. Oxford Capital seeks to back high-potential, disruptive technology with strong intellectual property or early signs of product-market fit. They typically aim to be the first institutional investor in these early-stage ventures, ranging from seed to Series A rounds. Their portfolio includes notable companies like Moneybox, Red Sift, and Attest. The firm prides itself on a hands-on approach, supporting founders with not only capital but also strategic guidance to help them achieve significant growth and scalability. The team, led by founder David Mott and including key members like Stephen Hampson and Chris Payne, brings a wealth of experience in venture capital and strategic investments. Oxford Capital's location in one of the world's leading knowledge clusters, Oxford, positions them advantageously to tap into cutting-edge innovations and support high-growth companies aiming to expand internationally.

Oxy Capital is a Lisbon-based private equity firm with a strong focus on supporting small and medium-sized enterprises (SMEs) through tailored investment strategies. Since its founding in 2011, Oxy Capital has concentrated on restructuring, private equity, mezzanine debt, and special situations. With over 25 professionals across offices in Lisbon and Milan, the firm manages a variety of funds, including the Fundo de Reestruturação Empresarial and Oxy Capital Mezzanine Fund, which emphasize economic revitalization and sustainable growth. Oxy Capital specializes in creative financing solutions, particularly for businesses facing operational challenges or in need of restructuring. Its investment philosophy is driven by flexibility and boldness, enabling the firm to venture into under-explored markets and deliver high returns for investors. The firm’s portfolio spans industries like manufacturing, energy services, and commercial products, with a clear focus on fostering competitiveness in its portfolio companies. Led by Managing Partner Miguel Lucas, the team prides itself on its hands-on approach, working closely with businesses to enhance value while offering deep market insights. Oxy Capital’s dual presence in Portugal and Italy gives it a strong foothold in Southern Europe, making it a key player in revitalizing SMEs across the region.

Oyster Ventures, founded in 2016 and headquartered in San Francisco, is a venture capital firm that targets early-stage investments in frontier technology companies. The firm aims to drive innovation by investing in startups that bring liquidity and efficiency to traditional industries, support globalization, and have significant scaling potential. Notable companies in their portfolio include Ridepanda, Rithmm, and Advance, reflecting their diverse investment interests in specialty retail, business productivity software, and financial software. Key exits like Postmates and Clearbit highlight their success. Led by Sophie Liao and Ran Wang, Oyster Ventures is known for its hands-on approach and strategic support, helping portfolio companies navigate the complexities of growth and scale. The firm is particularly interested in technologies that can disrupt and modernize outdated systems, making industries more efficient and globally accessible. Their investment strategy focuses on identifying and nurturing startups with the potential to become market leaders through innovative solutions and robust business models. This approach has positioned Oyster Ventures as a significant player in the venture capital landscape, dedicated to fostering technological advancements and supporting visionary entrepreneurs.

Ozmen Ventures is a Reno, Nevada-based early-stage venture capital fund founded in 2016 by Eren and Fatih Ozmen, the owners of Sierra Nevada Corporation (SNC), a global national-security contractor specializing in aircraft modification, space components and systems, cybersecurity, and eHealth with 5,000 employees across 40 offices. Kerem Ozmen serves as Principal and Managing Director, also a co-founder of 8090 Industries. Operating from the Innevation Center in downtown Reno, the fund was established to back innovative solutions to traditional problems in northern Nevada and beyond, with a deliberate goal of seeding a venture ecosystem in a state historically underserved by coastal capital. Sector focus spans aerospace, artificial intelligence, fintech, healthcare, advanced computing, and consumer internet, reflecting deep-tech adjacencies that align with the Ozmen family's SNC expertise. The firm has made approximately eight investments across seven portfolio companies. Notable portfolio names include FiscalNote, which listed on NASDAQ in December 2020 at a $219 million market cap and stands as Ozmen Ventures' only IPO exit to date, alongside Bloq, Luminous Computing, Self Lender, Covered, and ClickBio (laboratory consumables). Check sizes have ranged from seed through early Series A. Ozmen Ventures operates as a family-office vehicle with a concentrated, long-duration portfolio strategy. Its investment cadence is deliberately measured rather than high-frequency, reflecting a philosophy of making fewer, more deeply supported bets rather than diversifying broadly. The fund's strongest comparative advantage is its connection to SNC's national-security and space-technology customer base, which can provide portfolio companies with non-dilutive contracts and enterprise validation.

Pacific 8 Ventures is a Taiwan-based venture capital firm, primarily focusing on healthcare and disruptive technology platforms. Founded by Jack Liang, the firm targets early-stage companies, with a preference for being the first institutional investor. Pacific 8 Ventures invests in transformative technologies, especially those reshaping therapeutics, diagnostics, and broader health services. Their investment approach is global, with a strong emphasis on the U.S. market, where disruptive healthcare innovations are burgeoning​. Pacific 8 Ventures has built a diverse portfolio of companies at the forefront of healthcare innovation. Notable investments include Mammoth Biosciences, known for its pioneering work with CRISPR technology, and BillionToOne, which revolutionizes prenatal testing. They have also invested in companies like Fauna Bio, which uses mammalian genetic data for novel therapeutics, and Dorian Therapeutics, focused on anti-aging technologies. The firm is also involved in significant collaborations, such as Mammoth Biosciences' $1 billion partnership with Bayer. Pacific 8 Ventures is dedicated to helping companies navigate the challenges of scaling in the competitive healthcare landscape, leveraging deep expertise and strategic support to drive success.

Pacific Health Ventures (PAC.VC) is a Silicon Valley-based healthcare venture capital firm founded in 2019 and headquartered in Menlo Park, California. The firm is an early-stage investor focused exclusively on B2B health technology, backing software-as-a-service platforms that improve clinical outcomes, streamline clinical and administrative workflows, and unlock new revenue for healthcare providers, payers, pharma companies, and employer customers. Pacific Health Ventures operates with a lean two-person investment team and runs a strategy of matching early-stage startups with strategic industry partners that have relevant gaps in their technology and service offerings, coupling seed and Series A capital with distribution and validation from large health-system and enterprise partners. The firm has built a concentrated portfolio of five active companies. Notable investments include SafelyYou (AI-powered fall prevention for senior living), Limbix (adolescent mental-health digital therapeutics), and Sika Health (HSA and FSA payments infrastructure). Pacific Health Ventures has made four Series A investments with an average round size of $12.7 million. The firm's most recent activity includes the Feeling Great $12 million Series A and the Relief Cardiovascular Series A, both announced in January 2025. Pacific Health Ventures distinguishes itself through its partner-matching model, which creates a pathway for portfolio companies to land and expand within large health enterprise customers before scaling broadly. This approach reduces the cold-start problem endemic to health technology sales cycles and gives founders both the capital and the institutional relationships needed to cross the proof-of-concept threshold into recurring enterprise revenue.

Page One Ventures is an early-stage Silicon Valley venture capital firm founded in 2020 by General Partner Mo El-Bibany and headquartered in San Francisco. The firm invests in software transforming existing markets and in deep technology creating entirely new ones, with stated focus areas in life sciences, deep tech, and B2B SaaS, with particular emphasis on data infrastructure and AI. Its thesis, captured in the firm's own phrasing, is that the future will be 'written in code and in codons,' reflecting a deliberate barbell between software and biology or hardware frontiers. The team of seven spans the United States and United Kingdom, with Venture Partners Ameena El-Bibany and Marc-Alexandre Saba complementing the founding GP. Through prior funds, the partners have backed more than 50 companies that have gone on to raise more than $1.5 billion in follow-on financing at an aggregate enterprise value exceeding $20 billion. As of October 2025, the Page One portfolio numbered approximately 68 companies across seed and Series A, including five unicorns and five acquired companies. Headline names include Dapper Labs, DataRobot, Ayar Labs (which reached unicorn status in 2024), and Portal Biotechnologies. The most recent reported new investment is GRO Biosciences in July 2024, and the most recent exit was Teampay, acquired by PayStand in April 2024. Page One takes a conviction-driven, founder-centric approach, deploying across both pre-seed and seed stages. The firm's interdisciplinary perspective across software and life sciences allows it to evaluate companies at the intersection of biology and computation that generalist funds may be poorly positioned to underwrite.

Paladin Capital Group is a global venture capital firm based in Washington, D.C., with additional offices in New York, Silicon Valley, London, and Luxembourg. Since its inception in 2001, Paladin has managed over $1 billion in committed capital, investing in more than 65 companies across North America, Europe, Australia, and South America. The firm focuses on innovative technology, particularly in cybersecurity, which has become a primary area of expertise. Notable investments include Corellium, which specializes in mobile and IoT virtualization; Digital Shadows, a provider of cyber situational awareness; and Expel, a company offering transparent managed security. Other significant portfolio companies include RangeForce, which offers a cyber simulation and skills analytics platform, and Hack The Box, an online cybersecurity training platform. Paladin Capital Group employs a dual-use investment approach, leveraging its knowledge of both commercial and government markets to provide unique insights and opportunities for its portfolio companies. This strategy helps startups develop strategic partnerships, access new markets, and navigate financing options. The firm is committed to adding value beyond capital by supporting portfolio companies with strategic guidance and leveraging its extensive network to maximize returns. Paladin has been actively involved in numerous successful exits, including the sale of Hubble Technologies to KKR-backed NetSPI.

Pallasite Ventures is a venture capital firm that focuses on providing early-stage financing to high-growth companies across a variety of industries, including tech and consumer products. Founded in 2012 and based in Vancouver, Canada, Pallasite Ventures aims to fund companies whose leaders have the vision and skill to transform their markets. The firm is particularly active in Seed and Series A deals, offering investments ranging from $100,000 to $1.5 million USD and maintaining significant reserves to support their portfolio companies as they grow. The firm has invested in over 60 companies, including notable names like Dooly, Prescryptive, and CalypsoAI. Pallasite Ventures places a strong emphasis on adding value and providing support to its portfolio companies, ensuring they have the resources and freedom needed for long-term growth. The firm's investment focus spans multiple regions, including Vancouver, San Francisco, Boston, Denver, Chicago, and Toronto. Pallasite Ventures is led by Managing Partner Christopher Bissonnette, Ph.D., and operates with an agile and supportive approach, aiming to streamline decisions and provide strategic advice to its investments​.

Palm Drive Capital, headquartered in New York City with additional offices in San Francisco and Taipei, is a venture capital firm that specializes in early-stage investments. Founded in 2014, the firm primarily backs Seed and Series A tech founders across SaaS, AI, fintech, and e-commerce sectors. Their global approach underscores their belief that "innovators are everywhere," supporting startups from diverse geographical regions​. The firm has a notable portfolio, including investments in Deep Instinct, a leader in cybersecurity, and MoneyLion, a modern challenger bank. Palm Drive Capital has also achieved significant exits, such as those from Clover Health and Long Game, highlighting their success in identifying and nurturing high-potential startups​. Palm Drive Capital prefers a collaborative investment approach, frequently co-investing with other venture firms rather than leading rounds. Their strategy focuses on scalable solutions in high-growth markets, providing not only financial support but also strategic guidance through their extensive network. This approach has positioned them as a valuable partner for early-stage companies looking to scale efficiently. Led by co-founders Hendrick Lee and Seamon Chan, the team comprises experts like Catherine Cai and Nick Hsu, who contribute significant investment and operational expertise. For startups aiming to engage with Palm Drive Capital, demonstrating a robust product-market fit and a clear scalability plan is crucial. The firm values well-prepared pitches that highlight market opportunities and strategic growth plans​.

Palm Venture Studios is a turnaround-focused venture studio established in 2021 by the Palm Ventures family investment office, itself founded by Brad Palmer in 1992. Headquartered in Austin, Texas, with offices in Boston, Philadelphia, Las Vegas, Columbus, Hudson NY, and Salt Lake City, the firm pioneered what it calls 'second-chance' capital: investment in purpose-driven but financially stuck early-stage startups that have built real product traction yet run into a capital-structure wall. Palm's thesis recognizes that many promising companies are not failing on product but on cash flow, and that what they need is a combination of restructuring, fresh capital, and operational rebuilding rather than a standard growth check. Executive Chair Brad Palmer, who sits on the Project Drawdown board, co-founded the studio alongside Managing Partner Daniela Plattner. The firm concentrates on companies working on human and planetary health, spanning healthtech, sustainability, AI, and SaaS. Across its lifetime Palm has invested second-chance capital into more than 25 early-stage, mission-driven businesses. Notable portfolio companies include Camio, which built computer-vision and AI safety-monitoring technology deployed across 14 countries before hitting a near-death cash crunch and being restarted with Palm's backing, and Kashew, a SaaS platform helping resale businesses build digital storefronts that reportedly lifted reseller revenue by up to 20 percent in a single month. Palm Venture Studios takes meaningful ownership stakes and pairs patient capital with deep operational support, engaging at the governance and go-to-market level rather than simply writing a check. Its distributed multi-city footprint allows it to source overlooked opportunities outside the traditional coastal VC hubs.

Palomar Ventures is a Los Angeles-area venture capital firm launched in 1999 by veteran venture capitalists focused on early-stage information technology companies with the potential for exceptional growth and market leadership. Headquartered in Santa Monica, California, the firm invested across three institutional funds culminating in Palomar III, a $225 million vehicle that brought cumulative capital under management to more than $500 million. Managing Director Jim Gauer led the firm with Chief Financial Officer Lisa Riedmiller, and across Palomar's lifetime its partners contributed to building nearly 50 public companies. Palomar's investment thesis centered on identifying disruptive, scalable IT businesses from the earliest stages, concentrating on infrastructure software, networking and telecom infrastructure, next-generation storage, wireless solutions, and security. Typical new investments were $2 million to $5 million, and the firm led or co-led rounds early in value formation, working closely with founders on strategy, corporate development, and executive recruiting. Palomar has made 124 investments and recorded 38 exits, including Composite Software (acquired by Cisco Systems in June 2013), Paymetric, Ace Metrix, and MyBuys. The firm's most recent publicly recorded new-money investment was in Predixion Software's Series D in April 2015. Since 2015 Palomar has been managing its legacy portfolio rather than raising or deploying a new fund. Its historical strength in enterprise software and network infrastructure gave it a strong track record across the dot-com and post-crash eras, and the firm's partners remain respected figures in the Southern California and broader US technology investment community.

Palumni VC is a Miami, Florida-based early-stage venture capital firm founded in 2020 by Founding Partner Luba Lesiva with a narrow, proprietary thesis: invest exclusively in the next generation of companies founded and led by Palantir alumni. SEC-registered as PALUMNI VC, LLC (Firm #321066), the firm draws on a private investor network of more than 600 operators, founders, and angels, almost all of them ex-Palantir, to serve as the connective tissue of the Palantir diaspora. The goal is to be the most value-add investor per dollar on the cap table of every portfolio company, through strategic introductions, operator-driven advice, and follow-on support along the full founder journey. Palumni is not constrained by stage, sector, or geography, though its sweet spot is high-signal seed and Series A rounds in software, analytics, AI and machine learning, enterprise SaaS, and HR and recruiting. Typical check sizes are $200,000, with an overall range of roughly $150,000 to $1 million. The firm also operates an AngelList syndicate to enable its alumni network to co-invest pro rata. Across 80 investments, named portfolio companies include Adyton, Kairos, Kolena, Kurtosis, Little Otter (children's mental health), Metaview (AI interviewing), and Mural (collaborative whiteboarding). The most recent publicly recorded investment is Digger, a software development applications company, in June 2025. Palumni VC's edge is sourcing: founders who are Palantir alumni have a demonstrated track record of building complex data and analytics infrastructure, and the firm's alumni network provides a pre-vetted funnel of high-caliber operators building their own companies.

Panacea Venture is a global healthcare-focused venture capital fund with a strong track record in early-stage life sciences investments. Spun out of Kleiner Perkins, Panacea specializes in building innovative companies that target unmet medical needs, particularly in biotech, therapeutics, and medical devices. Their investment scope spans cell and gene therapies, diagnostics, and emerging technologies like AI-driven healthcare solutions. With a global reach, Panacea has offices in Shanghai, Boston, and Silicon Valley, leveraging its cross-border expertise to tap into transformative healthcare innovations across North America and Asia. The firm is highly active, leading early-stage rounds and often taking board seats, while its venture operator model allows them to incubate and actively manage portfolio companies. Notable portfolio names include groundbreaking companies in immunotherapy and gene editing, such as TriArm Therapeutics and Kindstar Global. Panacea’s investment approach focuses on deep due diligence and long-term partnerships. They seek companies with strong scientific foundations and scalable technologies, preferring founders with deep domain expertise. The fund’s managing partner, James Huang, along with a diverse team of venture partners, brings over 100 years of combined experience in both venture capital and life sciences industries. They continue to focus on early-stage growth, with an emphasis on hands-on involvement to drive value from inception to public market success.

Panache Ventures is a leading Canadian venture capital firm specializing in early-stage investments, particularly at the pre-seed and seed stages. Founded in 2018, the firm has a strong national presence with offices in Vancouver, Calgary, Toronto, and Montreal. Panache Ventures focuses on supporting ambitious entrepreneurs across various sectors, including enterprise software, AI/ML, fintech, blockchain/web3, health tech, and climate tech. Panache Ventures' first fund raised over $58 million and invested in 100 companies, achieving notable exits such as fintech company Flinks and proptech company Lane. Their second fund, Panache Ventures II, closed at $100 million, with significant investments from Alberta Enterprise Corporation, Ontario Capital Growth Corporation, Investissement Québec, BMO Financial Group, and TELUS Ventures. This fund aims to double down on pre-seed and seed investments in Canadian technology startups, supporting around 20 new investments per year​. The firm is known for its commitment to diversity and inclusion, with 52% of its portfolio companies being led by persons of color and a rate of investment in women-led startups that is 1.8 times the national average for Canadian venture capital​​. Panache Ventures emphasizes a founder-friendly approach, providing extensive mentorship and support throughout the growth of their portfolio companies. Key team members include Chris Neumann, Scott Loong, Prashant Matta, and Patrick Lor, who collectively bring a wealth of experience and expertise to the firm.

Panakès Partners, based in Milan, is a leading venture capital firm specializing in life sciences. Founded by Diana Saraceni, who has over 20 years of experience in the VC industry, the firm focuses on early-stage startups and SMEs developing innovative technologies in biotech, diagnostics, and medical devices. Their portfolio includes notable investments like EndoStart and Diadem, reflecting their commitment to groundbreaking solutions in healthcare. Panakès primarily targets Europe and Israel, aiming to address significant unmet medical needs with a robust ESG framework. Their latest €175 million fund, the Purple Fund, emphasizes Series A investments, supporting around 15-18 companies with average checks ranging from €5 to €10 million. Known for leading rounds, Panakès actively engages with startups through a rigorous selection process, valuing sustainability and impactful health solutions. The team, led by Saraceni, brings extensive expertise and a strong network in the life sciences sector, bolstered by their participation in various national and international advisory boards. For entrepreneurs, Panakès is approachable via direct submissions to their email, fostering a transparent and accessible investment process.

Pangaea Ventures is a world-leading hard-technology venture capital firm founded in 2000 by Founding General Partner Chris Erickson (formerly a partner at Osler, Hoskin and Harcourt specializing in environmental and corporate law), Purnesh Seegopaul, and David Weekes. Headquartered in Vancouver, British Columbia with an additional office in Phoenix, Arizona, the firm backs early-stage companies leveraging advancements in advanced materials, chemistry, and biology to address large global challenges and enable a sustainable future. Across five funds, the firm has targeted multi-trillion-dollar market opportunities in energy, electronics, health, and sustainability. Fund IV was a $100 million vehicle, and Fund V, the Pangaea Ventures Impact Fund, held its final close in April 2024 at CAD 115 million, planning approximately 10 to 12 Series A investments with typical checks of $3 million to $5 million. Pangaea leads rounds and operates with a team of 16, including six partners such as Andrew Haughian, who joined in 2006 and leads materials-science coverage. The firm has invested in 42 companies and has recorded 12 portfolio exits to date. Portfolio highlights include Aspect Biosystems (bioprinted tissue), Calysta (gas-fermentation protein), CarbonCure (carbon-sequestering concrete, with $169 million-plus raised), ESS (iron flow batteries), Redlen Technologies (medical imaging), Vestaron (bio-pesticides), and Nautilus Data Technologies. In 2025 the firm completed three new investments, with the most recent being pH7 Technologies' Series B in December 2025. Pangaea Ventures brings deep technical diligence capability, scientific networks, and long-duration patient capital to founders commercializing laboratory breakthroughs in materials and chemistry. Its specialist positioning within hard tech makes it one of the few funds globally with the expertise and conviction to lead seed and Series A rounds in the advanced-materials category.

Panoramic Ventures, also known as BIP Ventures, is a venture capital firm that invests in early-stage and growth-stage technology companies. With a strong focus on supporting the innovation economy, Panoramic Ventures partners with entrepreneurs to build impactful businesses across diverse industries. Founded as BIP Capital, the firm has a robust portfolio and offers comprehensive private market investment solutions. Their investment strategy is centered around identifying high-potential startups and providing them with the necessary capital and strategic guidance to scale successfully. Panoramic Ventures has a notable portfolio of companies, including OncoLens, which specializes in oncology management solutions, and Acclivity Health Solutions, which focuses on improving end-of-life care through advanced technology platforms.

Pantera Capital is a pioneering venture capital firm focused exclusively on blockchain and cryptocurrency investments. Founded by Dan Morehead in 2003, Pantera launched the first cryptocurrency fund in the U.S. in 2013 when Bitcoin was valued at $65 per BTC. They have since introduced various funds, including the first blockchain-focused venture fund and the first early-stage token fund in 2017. Pantera manages $5.6 billion in assets, providing investors with comprehensive exposure to the blockchain ecosystem through venture equity, early-stage tokens, and liquid tokens. Their investment strategy is global, having backed over 100 blockchain companies and 110 early-stage token deals across sectors like decentralized finance (DeFi), next-gen payment systems, and institutional trading tools. The firm's notable funds include the Pantera Venture Funds, Pantera Bitcoin Fund, Pantera Liquid Token Fund, and the all-encompassing Pantera Blockchain Fund. Their extensive portfolio features key players in the blockchain space, contributing significantly to the industry's infrastructure and growth. Pantera Capital operates from offices in the Bay Area, New York, and Puerto Rico, with a team of seasoned professionals bringing decades of experience from top-tier financial firms and technical backgrounds.

Paperclip Ventures is a San Francisco-based early-stage venture capital firm founded in 2017 that positions itself as a SaaS-only investment partner for B2B and B4B (business-for-business) founders. The firm's thesis targets pre-Series A SaaS companies with less than $5 million in revenue that have a credible path to $500,000 in monthly recurring revenue within 12 to 24 months and a Series A raise within 18 to 24 months of initial investment. Paperclip also runs an AngelList syndicate alongside its primary fund to enable its operator network to co-invest in deals. The team brings more than 40 years of combined startup operating and private-equity-backed operating experience alongside more than 20 years of venture capital and angel-investing experience. Each partner is a SaaS specialist, and Paperclip openly positions itself as a hybrid VC and consulting partner, offering hands-on product and go-to-market support branded as 'SaaS Venture Consulting.' The firm has made 15 investments across SaaS, B2B software, and media and information services. Named portfolio companies include Tailwind IT, Decklinks, and Velocity. The most recent publicly recorded investment is Tailwind IT in June 2022, with no new deployments publicly disclosed since, suggesting the firm is largely in portfolio-management mode. Paperclip Ventures suits founders who want deep operational engagement alongside capital, particularly those building enterprise SaaS businesses who can benefit from hands-on go-to-market support, product strategy input, and connection to the firm's operator network at a stage where most investors offer only a board seat.

Pappas Capital is a prominent venture capital firm based in Durham, North Carolina, specializing in investing in next-generation life science, agriculture, and technology companies. Established in 1994 by Art Pappas, the firm has a robust track record of investing in over 90 companies across the United States, Canada, and Asia. Their investments focus on innovative solutions that address significant unmet medical needs and span a wide range of diseases, including cancer and hemophilia​. Pappas Capital operates through three primary divisions: Pappas Ventures, Specialized Fund Management, and Translational Medicine. Pappas Ventures is their flagship arm, dedicated to life science investments, particularly in undercapitalized markets. Specialized Fund Management creates and manages custom investment vehicles, while Translational Medicine partners with academic institutions to accelerate the development of scientific discoveries. The firm boasts a seasoned team of investment professionals, including Art Pappas, Elizabeth Kelly, and Barry Myers, who bring extensive experience in pharmaceuticals, biotechnology, and venture capital. This expertise enables Pappas Capital to provide valuable insights and strategic guidance to their portfolio companies, helping them navigate the complexities of drug development and commercialization. Pappas Capital has successfully guided numerous companies to significant exits, including IPOs and acquisitions. Recent investments include companies like VFlow Tech and Enlaza Therapeutics, further emphasizing their commitment to advancing groundbreaking life science technologies​.

Parade Ventures is a venture capital firm focused on pre-seed and seed-stage investments, primarily in enterprise technology companies. Founded by Shawn Merani in 2018, the firm is headquartered in Los Gatos, California. Parade Ventures targets businesses with recurring revenue models, strong capital efficiency, and scalable operations. They lead or co-lead early-stage funding rounds, often being the first institutional money into a company. Shawn Merani, with extensive experience in early-stage investing and entrepreneurship, has backed successful companies like Dollar Shave Club, Moveworks, and Trusted Health. He was also a founding partner of Liquidnet’s Private Shares marketplace, showcasing his deep expertise in tech and private market investments. Parade Ventures' investment thesis revolves around identifying companies with high margins, lifetime value, and repeatable sales models. The firm emphasizes capital-efficient businesses that can scale sustainably, and it provides portfolio companies with unparalleled access to a network of top-tier founders and operators for mentorship and support. Notable investments include companies such as Plastiq and Clubhouse, reflecting Parade Ventures' focus on cutting-edge technology and scalable solutions in industries like software, financial services, and productivity tools. Parade Ventures continues to be a key player in helping early-stage tech companies navigate their growth journeys.

Paradigm Ventures is a prominent venture capital firm that excels in investing within the cryptocurrency and blockchain technology sectors. Their portfolio boasts notable investments such as Coinbase, Chainalysis, and OpenSea, reflecting their strong presence in the digital assets space. They focus on investing in early-stage ventures but also support companies through various growth stages with investment sizes ranging from $1M to $100M. Paradigm's investment strategy is deeply research-driven, often leading rounds and providing significant hands-on support in areas like technical mechanism design, smart contract security, and operational scaling. This approach not only ensures the technological robustness of their portfolio companies but also aids in achieving long-term growth and market leadership. Geographically, Paradigm is heavily invested in the United States, particularly within major tech hubs such as San Francisco. However, their investments and interest span globally, targeting innovative companies that push the boundaries of blockchain technology. Paradigm prefers to be approached by startups with a clear and compelling vision for their technology and its impact on the crypto ecosystem. They are highly selective, looking for teams with strong technical foundations and a demonstrated ability to execute their vision effectively.

Pareto Holdings, founded by Edward Lando and Jon Oringer in 2020, is a Miami-based venture capital firm specializing in early-stage investments. The fund has a dynamic portfolio that includes notable companies such as Burnbot, nsave, and Elevated Signals, reflecting its focus on Environmental Services (B2B), Financial Software, and Business/Productivity Software industries. Pareto Holdings primarily targets startups with high potential for globalization, emphasizing early growth companies with significant momentum. Geographically, the firm maintains a strong presence in the U.S., with a particular focus on the Miami entrepreneurial ecosystem. The investment strategy at Pareto Holdings involves being one of the first backers of exceptional entrepreneurs. They typically lead funding rounds and are known for their active involvement in their investments. The average check size varies, but they maintain a hands-on approach, often participating in the operational aspects of the startups they invest in. Approaching Pareto Holdings requires demonstrating high growth potential and a clear path to global expansion. They value innovation and market disruption, looking for teams that can leverage their extensive network and resources effectively. The leadership team at Pareto Holdings includes Edward Lando, Jon Oringer, Rohit Bhadange, Annie Wasserman, and Benjamin-Jean Cambier, all based in Miami. This diverse team brings a wealth of experience in venture capital and business development, ensuring robust support for their portfolio companies.

Pario Ventures is a UK-based early-stage venture capital firm founded in 2010 by CEO and Co-Founder David Murray-Hundley and Co-Founder Kevin Doyle, headquartered on the Isle of Wight in Cowes. The firm backs founders and early-stage companies worldwide from seed through Series A and beyond, offering capital, strategic advice, and real-world operational support. Pario has approximately GBP 45 million available to deploy, with a typical check size of around $2 million within a $1 million to $10 million range, allowing it to lead smaller rounds or co-invest in larger ones. Brand, marketing, and communications strategist Trina Murray-Hundley leads operational support for portfolio companies. The firm received the 2024 Private Equity and Venture Capital Award from Wealth and Finance International. Pario leads rounds and has made more than 110 investments, with the firm's own site claiming over 140 portfolio companies, spanning automotive and mobility, hospitality, fintech, payments, blockchain, software, technology, and communications. Named portfolio companies include Axonyz.ai (commercial AI products, most recent investment in October 2025), Pario Azure (cloud services), and SWOP, a UK-based peer-to-peer blockchain-powered marketplace for trusted trading of physical and digital items. The firm co-invests across European and US-based startups. Pario Ventures takes a hands-on approach to portfolio engagement, with operational support extending well beyond board-level governance. Its founding team's background in building and scaling businesses provides founders with practitioner-grade advice on commercial strategy, brand positioning, and fundraising, particularly relevant for early-stage companies navigating growth across multiple geographies.

Paris Ventures is the historical Crunchbase identity of Gerdau Next Ventures, the corporate venture capital arm of Brazilian multinational steelmaker Gerdau S.A. Launched around 2020 and operating out of Sao Paulo, Brazil, the program invests in and supports entrepreneurs transforming the built world, bringing Gerdau's scale in manufacturing, metallurgy, recycling, and construction supply chains to portfolio companies. Unlike a pure financial investor, Gerdau Next Ventures pairs capital with concrete operational support, including consultation on manufacturing and metallurgy, management advisory, executive connections across Gerdau's global footprint, and commercial introductions to large construction, automotive, and industrial customers worldwide. The investment focus spans construction technology, logistics and supply chain, recycling and advanced materials, data and artificial intelligence, and renewable energy. The firm has made approximately 15 investments. Notable portfolio companies include Plant Prefab (US-based prefabricated construction, Series C), Docket (business document management), Aifleet (trucking), Cubbo (e-commerce logistics in Latin America), and Instacasa (Brazilian proptech). The firm does not publicly disclose fund size, check sizes, or a named partner roster, reflecting its balance-sheet corporate venture structure rather than a third-party-raised vehicle. The unit underwent a significant restructure in 2024 and 2025, with Gerdau effectively re-internalizing its corporate venture activity under the parent company's own corporate structure, leaving the Paris Ventures and Gerdau Next Ventures brands in a quiet period with limited new public deployments. The firm's strategic value to portfolio companies historically derived from Gerdau's position as one of the Americas' largest steel producers with deep relationships across construction and industrial sectors.

Pathbreaker Ventures, established in 2016 and based in San Francisco, focuses on early-stage investments in startups tackling significant global challenges with innovative hardware and software solutions. Led by Ryan Gembala, the firm supports specialized engineering and product leaders, often investing when a company is still in its foundational stage. Pathbreaker invests in sectors like AI, robotics, and deep tech, targeting problems valued at over $100 billion​. Ryan Gembala, the Founder and Managing Partner, has a rich background in venture capital and corporate development, having previously worked at Facebook and Azure Capital. His experience spans the full startup lifecycle, from founding and operating companies to investing and acquiring venture-backed firms​. Pathbreaker Ventures' portfolio includes companies like Spiketrap, an AI for real-time language understanding, and Mux, which builds video streaming and analytics APIs. The firm co-invests with top-tier venture firms and is known for its hands-on approach, providing capital, strategic advice, and access to a vast network of industry experts.

Patricof Co (P/Co) is a New York-based investment and advisory platform founded in late 2018 by Mark Patricof, former investment banker and son of legendary venture capitalist Alan Patricof, founder of Apax Partners and Greycroft. The firm was built around a structural insight: world-class professional athletes have cultural relevance, brand-building capability, and capital of their own, and if organized properly they become an unusually privileged source of deal flow and post-investment value creation for growth-stage consumer private equity. Patricof Co acts as curator and general partner of this ecosystem, sourcing and advising on late-stage venture and private equity deals, structuring athlete co-investments on a limited-partner basis, and leveraging its athletes' platforms to accelerate brand building, cultural marketing, and corporate governance at portfolio companies. The athlete roster has grown from roughly 85 at launch to approximately 250, including Venus Williams, J.J. Watt, Travis Kelce, Blake Griffin, Kemba Walker, CC Sabathia, George Kittle, and Trea Turner. Patricof Co deployed around $75 million in 2021 alone and, to date, has committed more than $135 million in consumer private-equity capital across 16-plus investments. Two notable realized outcomes stand out: Cholula Hot Sauce, acquired by McCormick for $803 million in late 2020, and The RealReal, which IPO'd in 2019 at a $2.32 billion valuation. Active portfolio deals include Virgin Voyages, TopGolf, and Orgain. The firm occupies a distinct niche at the intersection of consumer investment and athlete-driven cultural marketing. Founders backed by Patricof Co gain not only capital but also access to athlete relationships that can amplify brand awareness and consumer trust in ways traditional institutional investors cannot replicate.

PBM Capital, founded by entrepreneur Paul Manning in 2010, is a dynamic healthcare-focused investment firm with a strong emphasis on pharmaceuticals, biotechnology, and life sciences. Headquartered in Charlottesville, Virginia, with an additional office in New York, PBM partners with scientists and innovators to create groundbreaking therapies that significantly improve patient outcomes. Their team provides capital along with critical operational and strategic expertise, helping companies navigate complex healthcare markets and scale rapidly. PBM’s portfolio boasts several notable successes, including AveXis, which was acquired by Novartis for $8.7 billion, and Dova Pharmaceuticals, which completed an IPO before being acquired by Swedish Orphan Biovitrum. The firm seeks out companies with revolutionary science and strong leadership, focusing on areas such as gene therapy, biologics, and drug development. PBM takes an active role in guiding its investments, offering not only funding but also leveraging its extensive network to accelerate commercialization. Their investment strategy centers around long-term value creation, seeking out companies with life-changing technologies and the potential to transform healthcare. By combining operational experience with capital investment, PBM aims to help founders bring revolutionary therapies to market and create lasting impact​.

Peak State Ventures, founded in 2017 and based in New York City, is a venture capital firm that focuses on investing in the future of work, PropTech, and digital healthcare. The firm supports early-stage companies and aims to back visionary founders who are transforming industries through technology. Peak State Ventures invests in seed and early-stage companies, providing both capital and strategic guidance. The firm has a diverse portfolio that includes notable companies like Snapdocs, Turing, and Mighty Buildings. Snapdocs is a leader in real estate transaction automation, while Turing democratizes the labor market by connecting U.S. companies with remote software engineers from around the world. Mighty Buildings focuses on 3D printing and sustainable construction technologies. Other portfolio companies include Feather, Brilliant, Raise, Stensul, and Ironclad. Peak State Ventures is led by a team of experienced entrepreneurs and investors. Key members include Jason Freedman, Bryan Ciambella, Omri Barzilay, Rajit Malhotra, and Seva Zakharov. They bring extensive experience in startup operations, investment, and strategic development, helping portfolio companies navigate growth challenges and achieve their business objectives.

PeakBridge VC is a venture capital firm focused on Agri-FoodTech, investing in companies that address major challenges in the global food system. Founded in 2016 and headquartered in Malta, PeakBridge aims to create long-term impact by investing in startups that drive sustainable solutions, improving both environmental and health outcomes across the food chain. The firm’s investment strategy is centered on five key areas: ingredient innovations, alternative protein technologies, food system digitalization, nutrition & health, and alternative farming systems. By investing in these sectors, PeakBridge helps startups scale solutions that tackle issues such as food waste, nutrition deficiencies, and the carbon footprint of food production. Its portfolio includes innovative companies like Standing Ovation (dairy substitutes through microbial fermentation), Vow (cultured meat), and Rival Foods (plant-based protein). PeakBridge operates through its FoodSparks® Seed Fund for early-stage European and Israeli startups, and Growth II Fund for Series A-B investments in Europe, the U.S., and Israel. The firm’s total assets under management exceed $250 million, with significant backing from Edmond de Rothschild Private Equity. As an Article 9 fund under the Sustainable Finance Disclosure Regulation (SFDR), PeakBridge integrates strict ESG principles into its investments, ensuring all portfolio companies contribute to a healthier and more sustainable food system.